New Ray Medicine (06108) Updates Monthly Securities Movements for November 2025

Bulletin Express12-02

New Ray Medicine International Holding Limited (stock code: 06108) submitted its Monthly Return for Equity Issuer, covering the period ended 30 November 2025. According to the announcement, the authorized share capital remained at 15,000,000,000 ordinary shares, each with a par value of HKD0.01, totaling HKD150,000,000. There was no change from the previous month.

The company’s issued share capital stayed at 167,184,665 ordinary shares without any treasury shares, reflecting no increase or decrease during the reporting period. Under the share option scheme adopted on 25 October 2013, 12,820,000 share options remained outstanding at the end of November 2025. No new shares were issued, and no funds were raised from exercise of options during the month.

Based on the disclosure, there were no movements in warrants, convertibles, or other share issuance agreements. The company confirmed that all applicable listing and regulatory requirements have been met for the period under review.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171136062?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171136062","market":"us","top_or_hot":-1,"title":"New Ray Medicine (06108) Updates Monthly Securities Movements for November 2025","media":"Bulletin Express","content":"<p>New Ray Medicine International Holding Limited (stock code: 06108) submitted its Monthly Return for Equity Issuer, covering the period ended 30 November 2025. According to the announcement, the authorized share capital remained at 15,000,000,000 ordinary shares, each with a par value of HKD0.01, totaling HKD150,000,000. There was no change from the previous month.</p>\n<p>The company’s issued share capital stayed at 167,184,665 ordinary shares without any treasury shares, reflecting no increase or decrease during the reporting period. Under the share option scheme adopted on 25 October 2013, 12,820,000 share options remained outstanding at the end of November 2025. No new shares were issued, and no funds were raised from exercise of options during the month.</p>\n<p>Based on the disclosure, there were no movements in warrants, convertibles, or other share issuance agreements. The company confirmed that all applicable listing and regulatory requirements have been met for the period under review.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Ray Medicine (06108) Updates Monthly Securities Movements for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Ray Medicine (06108) Updates Monthly Securities Movements for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-02 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>New Ray Medicine International Holding Limited (stock code: 06108) submitted its Monthly Return for Equity Issuer, covering the period ended 30 November 2025. According to the announcement, the authorized share capital remained at 15,000,000,000 ordinary shares, each with a par value of HKD0.01, totaling HKD150,000,000. There was no change from the previous month.</p>\n<p>The company’s issued share capital stayed at 167,184,665 ordinary shares without any treasury shares, reflecting no increase or decrease during the reporting period. Under the share option scheme adopted on 25 October 2013, 12,820,000 share options remained outstanding at the end of November 2025. No new shares were issued, and no funds were raised from exercise of options during the month.</p>\n<p>Based on the disclosure, there were no movements in warrants, convertibles, or other share issuance agreements. The company confirmed that all applicable listing and regulatory requirements have been met for the period under review.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06108","symbol_name":"新锐医药","start_time":0,"source_url":"","article_id":"1171136062","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171136062","pubTimestamp":1764665158,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"New Ray Medicine International Holding Limited (stock code: 06108) submitted its Monthly Return for Equity Issuer, covering the period ended 30 November 2025. According to the announcement, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06108":"新锐医药"},"translate_title":"新射线医学(06108)2025年11月证券变动月更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06108":1},"content_text":"New Ray Medicine International Holding Limited (stock code: 06108) submitted its Monthly Return for Equity Issuer, covering the period ended 30 November 2025. According to the announcement, the authorized share capital remained at 15,000,000,000 ordinary shares, each with a par value of HKD0.01, totaling HKD150,000,000. There was no change from the previous month.\nThe company’s issued share capital stayed at 167,184,665 ordinary shares without any treasury shares, reflecting no increase or decrease during the reporting period. Under the share option scheme adopted on 25 October 2013, 12,820,000 share options remained outstanding at the end of November 2025. No new shares were issued, and no funds were raised from exercise of options during the month.\nBased on the disclosure, there were no movements in warrants, convertibles, or other share issuance agreements. The company confirmed that all applicable listing and regulatory requirements have been met for the period under review.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171136062","isCrawlerRequest":true}